Angela Welle

Bachelor of Medicine and Bachelor of Science,  Cleveland Clinic 

Location: United States

Consulting Services

Legal Support Grant Submission Pharma-CRO-Device

Areas Of Interest

General Hospitals Long Non-Coding RNA Thesaurus, Controlled Dihydrate, Azithromycin Leukemia, Myeloid, Ph1 Positive Forteo DNA Breaks, Single-Strand Neoplasm, Urological Sanchinosides Temporary Amnesia Analgesia and Anesthesia Isothiocyanates Isolated Non-compaction of the Ventricular Myocardium PtdInsP Fredet-Ramstedt Operation Lymphoma, Nonhodgkins Lactobacillus salivarius Cladoceras Zinc Finger DNA Binding Domains Glioma, Retinal Elephant Seal Salmonella paratyphi B Pathway, JNK Co-Evolution, Biological Bone Marrow Fibroses Helix-Loop-Helix Motif Gene, X-Linked Maf Transcription Factors, Small Dental Restorations, Temporary CT Scanner, X Ray Calcium, Nadroparin Drugs, Radioprotective Patient Monitoring Ammonia-Lyase, Histidine Blood Coagulation Factor Deficiencies

Professional Narrative

Dr. Angela Welle was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Welle has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Medical Writer, Harvard Med 2014
Senior Director, Mayo Clinic 1992

Education

Doctor of osteopathic medicine, Baylor College 2018
Master of Science in physician assistant, Perelman School of Medicine 2007

Referees

Publications

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02